FY2024 EPS Estimates for Cross Country Healthcare, Inc. (NASDAQ:CCRN) Decreased by Analyst

Cross Country Healthcare, Inc. (NASDAQ:CCRN) – Stock analysts at William Blair cut their FY2024 earnings per share (EPS) estimates for shares of Cross Country Healthcare in a research report issued to clients and investors on Thursday, May 2nd. William Blair analyst T. Romeo now forecasts that the business services provider will post earnings per share of $0.75 for the year, down from their prior estimate of $0.95. The consensus estimate for Cross Country Healthcare’s current full-year earnings is $0.77 per share. William Blair also issued estimates for Cross Country Healthcare’s FY2025 earnings at $0.98 EPS.

Cross Country Healthcare (NASDAQ:CCRN) last announced its quarterly earnings results on Wednesday, May 1st. The business services provider reported $0.19 EPS for the quarter, topping the consensus estimate of $0.17 by $0.02. The company had revenue of $379.17 million for the quarter, compared to analyst estimates of $374.38 million. Cross Country Healthcare had a net margin of 2.58% and a return on equity of 11.69%. Cross Country Healthcare’s quarterly revenue was down 39.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.84 EPS.

Several other research firms have also issued reports on CCRN. Barrington Research decreased their price target on shares of Cross Country Healthcare from $24.00 to $21.00 and set an “outperform” rating on the stock in a research report on Monday. Benchmark decreased their target price on Cross Country Healthcare from $21.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Truist Financial cut their price target on Cross Country Healthcare from $22.00 to $16.00 and set a “hold” rating for the company in a report on Thursday, February 22nd. Finally, TheStreet lowered Cross Country Healthcare from a “b-” rating to a “c+” rating in a report on Friday, March 1st. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $20.83.

Cross Country Healthcare Trading Down 3.9 %

Shares of Cross Country Healthcare stock opened at $16.02 on Monday. Cross Country Healthcare has a 1-year low of $15.65 and a 1-year high of $28.75. The firm has a fifty day simple moving average of $17.90 and a 200-day simple moving average of $19.95. The stock has a market capitalization of $557.02 million, a price-to-earnings ratio of 12.32, a PEG ratio of 2.17 and a beta of 0.77.

Institutional Trading of Cross Country Healthcare

Large investors have recently made changes to their positions in the company. GAMMA Investing LLC bought a new position in Cross Country Healthcare during the 4th quarter worth about $28,000. Gladius Capital Management LP lifted its holdings in Cross Country Healthcare by 37.1% during the 4th quarter. Gladius Capital Management LP now owns 1,902 shares of the business services provider’s stock worth $43,000 after purchasing an additional 515 shares during the last quarter. Denali Advisors LLC boosted its position in shares of Cross Country Healthcare by 3,885.5% in the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider’s stock valued at $103,000 after acquiring an additional 5,362 shares during the period. Aigen Investment Management LP acquired a new position in shares of Cross Country Healthcare during the 3rd quarter worth approximately $219,000. Finally, Truvestments Capital LLC increased its position in shares of Cross Country Healthcare by 26.1% in the third quarter. Truvestments Capital LLC now owns 9,721 shares of the business services provider’s stock worth $241,000 after purchasing an additional 2,013 shares during the period. Institutional investors own 96.03% of the company’s stock.

Insider Buying and Selling at Cross Country Healthcare

In other Cross Country Healthcare news, insider Karen Mote sold 6,216 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $16.95, for a total value of $105,361.20. Following the transaction, the insider now directly owns 35,101 shares of the company’s stock, valued at $594,961.95. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 4.90% of the company’s stock.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.